EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms

Costanza Dieli, Roberta Costanzo, Anna Maria Corsale, Federica Paolini, Marta Di Simone, Claudia Avellone, Francesco Dieli, Domenico Gerardo Iacopino, Salvatore Marchiafava, Rosario Maugeri, Serena Meraviglia

Oncology Reviews · 02.07.2026 · 20

DOI: 10.3389/or.2026.1808229 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reviews, online erschienen am 02.07.2026. Verfasst von Costanza Dieli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) remains a highly aggressive brain tumor with limited treatment options and poor survival. The persistent clinical failure has driven interest in novel, immune-based strategies with higher specificity and greater cytotoxic potency, among which chimeric antigen receptor (CAR)-T-cell therapy has emerged as a leading approach. αβ CAR-T cells demonstrate safety but limited efficacy due to antigen heterogeneity, an immunosuppressive tumor microenvironment (TME), and restricted trafficking to the central nervous system (CNS). γδ CAR-T cells, combining innate major histocompatibility complex (MHC)-independent tumor recognition with engineered antigen specificity, have demonstrated preclinical cytotoxicity and features consistent with intratumoral persistence in selected models, as well as off-the-shelf potential, making them a next-generation immunotherapy strategy for GBM.

Schlagwörter

Stichwörter der Autor:innen

CAR-T cellsalpha/beta T-cellgamma delta T-cellglioblastomaimmunotherapy

Autor:innen und Institutionen

  • Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy.
  • Department of Precision Medicine in Medical, Surgical and Critical Care (MePreCC), University of Palermo, Palermo, Italy.
  • Developmental Biology and Cancer (DBC), UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Neurosurgery Unit, "Villa Sofia" Hospital, Palermo, Italy.
  • Department of Biomedicine, Neuroscience and Advanced Diagnosis (BiND), University of Palermo, Palermo, Italy.
  • Neurosurgery Unit, AOUP "Paolo Giaccone", University of Palermo, Palermo, Italy.

Förderung

  • European Commission

Zitieren

APA

Dieli, C., Costanzo, R., Corsale, A. M., Paolini, F., Di Simone, M., Avellone, C., Dieli, F., Iacopino, D. G., Marchiafava, S., Maugeri, R., & Meraviglia, S. (2026). CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms. Oncology Reviews, 20. https://doi.org/10.3389/or.2026.1808229

Vancouver

Dieli C, Costanzo R, Corsale AM, Paolini F, Di Simone M, Avellone C, et al. CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms. Oncology Reviews. 2026;20. doi:10.3389/or.2026.1808229

BibTeX
@article{Dieli2026,
  author = {Dieli, Costanza and Costanzo, Roberta and Corsale, Anna Maria and Paolini, Federica and Di Simone, Marta and Avellone, Claudia and Dieli, Francesco and Iacopino, Domenico Gerardo and Marchiafava, Salvatore and Maugeri, Rosario and Meraviglia, Serena},
  title = {CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms},
  journal = {Oncology Reviews},
  year = {2026},
  volume = {20},
  doi = {10.3389/or.2026.1808229}
}
Kostenlos starten →